The incidence of pancreatic adenocarcinoma has increased in recent decades and the prognosis for patients with this disease remains poor. New information about the pathogenesis of pancreatic cancer that has translational potential would be of great medical and economic importance. Cell culture and animal studies suggest that somatostatin can inhibit pancreatic cancer growth if the tumor cells express somatostatin receptors. Despite these promising results, recent clinical trials of somatostatin analogs as adjuvant treatment of pancreatic cancer have failed because most pancreatic cancer cells do not express somatostatin receptors. This application is centered on the hypothesis that functional somatostatin receptors maintain normal homeostasis within pancreatic cells and loss of these receptors is a critical step in pancreatic carcinogenesis.
Three specific aims will test this hypothesis by carefully defining both the mechanisms of somatostatin receptor loss and function in several experimental models. The first specific aim will, for the first time, carefully demonstrate the lack of expression of specific somatostatin receptor subtypes at both the mRNA and protein level in clinical samples of human pancreatic cancer and preneoplastic lesions. The molecular mechanisms responsible for somatostatin receptor gene silencing will be discovered.
The second aim will correlate the loss of somatostatin receptor expression to tumorigenicity in experimental models of pancreatic carcinogenesis. These experiments will be performed on cultured pancreatic cells and in an animal model. In vitro studies will examine multiple time points during carcinogen exposure for transformation and tumorigenicity while serial sacrifices of exposed animals will capture the progressive development of pancreatic cancer.
The third aim will determine which somatostatin receptor subtypes are important in the inhibition of pancreatic cancer growth. Each somatostatin receptor gene will be individually transfected into a human pancreatic cancer cell line that lacks somatostatin receptors. Effects on growth and responsiveness to somatostatin will be determined using tissue culture and xenografts in nude mice. The molecular mechanisms responsible for the growth inhibitory signal of each receptor subtype in human pancreatic cancer will be determined.
The aims outlined in this application will discover a novel aspect of pancreatic carcinogenesis. Gene therapy to restore the responsiveness of pancreatic cancer to somatostatin analogs by somatostatin receptor gene transfer may become possible from the knowledge gained in these experiments. Since somatostatin expression has been demonstrated in other tumor types, the findings may also be relevant to other cancers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08CA085822-02
Application #
6514456
Study Section
Subcommittee G - Education (NCI)
Program Officer
Eckstein, David J
Project Start
2001-07-01
Project End
2004-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
2
Fiscal Year
2002
Total Cost
$132,971
Indirect Cost
Name
Baylor College of Medicine
Department
Surgery
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Feurino, Louis W; Zhang, Yuqing; Bharadwaj, Uddalak et al. (2007) IL-6 stimulates Th2 type cytokine secretion and upregulates VEGF and NRP-1 expression in pancreatic cancer cells. Cancer Biol Ther 6:1096-100
Li, Min; Feurino, Louis W; Li, Fei et al. (2007) Thymosinalpha1 stimulates cell proliferation by activating ERK1/2, JNK, and increasing cytokine secretion in human pancreatic cancer cells. Cancer Lett 248:58-67
Li, Min; Zhai, Qihui; Bharadwaj, Uddalak et al. (2006) Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer 106:2284-94
Camacho, Diego; Reichenbach, Dan; Duerr, Georg D et al. (2005) Value of laparoscopy in the staging of pancreatic cancer. JOP 6:552-61
Li, Min; Yan, Shaoyu; Fisher, William E et al. (2005) New roles of a neuropeptide cortistatin in the immune system and cancer. World J Surg 29:354-6
Chen, Changyi; Li, Min; Chai, Hong et al. (2005) Roles of neuropilins in neuronal development, angiogenesis, and cancers. World J Surg 29:271-5
Chen, Changyi; Li, Min; Yang, Hui et al. (2005) Roles of thymosins in cancers and other organ systems. World J Surg 29:264-70
Li, Min; Fisher, William E; Kim, Hee Joon et al. (2005) Somatostatin, somatostatin receptors, and pancreatic cancer. World J Surg 29:293-6
Yao, Qizhi; Li, Min; Yang, Hui et al. (2005) Roles of cyclophilins in cancers and other organ systems. World J Surg 29:276-80
Li, Min; Zhang, Rongxin; Li, Fei et al. (2005) Transfection of SSTR-1 and SSTR-2 inhibits Panc-1 cell proliferation and renders Panc-1 cells responsive to somatostatin analogue. J Am Coll Surg 201:571-8

Showing the most recent 10 out of 16 publications